Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
2.
Int J Infect Dis ; 118: 197-202, 2022 May.
Artículo en Inglés | MEDLINE | ID: mdl-35257905

RESUMEN

OBJECTIVES: We described the current incidence and risk factors of bacterial co-infection in hospitalized patients with COVID-19. METHODS: Observational cohort study was performed at the Hospital Clinic of Barcelona (February 2020-February 2021). All patients with COVID-19 who were admitted for >48 hours with microbiological sample collection and procalcitonin (PCT) determination within the first 48 hours were included. RESULTS: A total of 1125 consecutive adults met inclusion criteria. Co-infections were microbiologically documented in 102 (9.1%) patients. Most frequent microorganisms were Streptococcus pneumoniae (79%), Staphylococcus aureus (6.8%), and Haemophilus influenzae (6.8%). Test positivity was 1% (8/803) for blood cultures, 10.1% (79/780) for pneumococcal urinary antigen test, and 11.4% (15/132) for sputum culture. Patients with PCT higher than 0.2, 0.5, 1, and 2 ng/mL had significantly more co-infections than those with lower levels (p=0.017, p=0.031, p<0.001, and p<0.001, respectively). In multivariate analysis, oxygen saturation ≤94% (OR 2.47, CI 1.57-3.86), ferritin levels <338 ng/mL (OR 2.63, CI 1.69-4.07), and PCT higher than 0.2 ng/mL (OR 1.74, CI 1.11-2.72) were independent risk factors for co-infection at hospital admission owing to COVID-19. CONCLUSIONS: Bacterial co-infection in patients hospitalized for COVID-19 is relatively common. However, clinicians could spare antibiotics in patients with PCT values <0.2, especially with high ferritin values and oxygen saturation >94%.


Asunto(s)
Infecciones Bacterianas , COVID-19 , Coinfección , Adulto , Infecciones Bacterianas/microbiología , COVID-19/epidemiología , Coinfección/epidemiología , Ferritinas , Hospitales , Humanos , Polipéptido alfa Relacionado con Calcitonina , Estudios Retrospectivos , SARS-CoV-2
3.
J Antimicrob Chemother ; 76(12): 3296-3302, 2021 11 12.
Artículo en Inglés | MEDLINE | ID: mdl-34473275

RESUMEN

BACKGROUND: The use of remdesivir has demonstrated a significant reduction in the time to recovery in patients with COVID-19. However, the impact on mortality is still controversial. Therefore, it is necessary to evaluate whether there is a specific subgroup of patients in whom an active antiviral therapy also reduces the mortality. METHODS: Patients admitted for >48 h in our hospital for a SARS-CoV-2 confirmed or suspected infection from February 2020 to February 2021 were retrospectively analysed. The primary outcome of the study was mortality at 30 days. Univariate and multivariate analyses were performed to identify predictors of mortality. RESULTS: In total, 2607 patients (438 receiving remdesivir and 2169 not) were included with a median (IQR) age of 65 (54-77) years and 58% were male. Four hundred and seventy-six were admitted to the ICU (18.3%) and 264 required invasive mechanical ventilation (10.1%). The global 30 day mortality rate was 10.7%. Pre-admission symptom duration of 4-6 days and ≤3 days was associated with a 1.5- and 2.5-fold increase in the mortality rate, respectively, in comparison with >6 days and treatment with remdesivir was independently associated with a lower mortality rate (OR = 0.382, 95% CI = 0.218-0.671). The analysis showed that the major difference was among patients with shorter pre-admission symptom duration (<6 days). CONCLUSIONS: Patients with ≤3 days and 4-6 days from symptom onset to admission are associated with a 2.5- and 1.5-fold higher risk of death, respectively. Remdesivir was associated with 62% reduced odds of death versus standard-of-care and its survival benefit increased with shorter duration of symptoms.


Asunto(s)
Tratamiento Farmacológico de COVID-19 , Adenosina Monofosfato/análogos & derivados , Anciano , Alanina/análogos & derivados , Antivirales/uso terapéutico , Humanos , Masculino , Respiración Artificial , Estudios Retrospectivos , SARS-CoV-2
4.
Infect Dis Ther ; 10(3): 1407-1418, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34115314

RESUMEN

INTRODUCTION: The study aim was to assess the influence of inflammatory response modifiers, including anti-interleukin-6 (IL-6) biologics and corticosteroids, on the incidence of hospital-acquired infections in patients with coronavirus disease 2019 (COVID-19). METHODS: Case-control study performed at a university hospital from February 26 to May 26, 2020. Cases were defined as patients with COVID-19 who developed hospital-acquired infections. For each case, two controls were selected among patients without infections. Cases and controls were matched obeying three criteria in a hierarchical sequence: length of hospital stay up until the first infection; comorbidity; and need for Intensive care unit (ICU) admission. Conditional logistic regression analysis was used to estimate the association of exposures with being a case. RESULTS: A total of 71 cases and 142 controls were included. Independent predictors for acquiring a hospital infection were chronic liver disease [odds ratio (OR) 16.56, 95% CI 1.87-146.5, p = 0.012], morbid obesity (OR 6.11, 95% CI 1.06-35.4, p = 0.043), current or past smoking (OR 4.15, 95% CI 1.45-11.88, p = 0.008), exposure to hydroxychloroquine (OR 0.2, 95% CI 0.041-1, p = 0.053), and invasive mechanical ventilation (OR 61.5, 95% CI 11.08-341, p ≤ 0.0001). CONCLUSIONS: Inflammatory response modifiers had no influence on acquisition of nosocomial infections in admitted patients with COVID-19. Hospital-acquired infections primarily occurred in the critically ill and invasive mechanical ventilation was the main exposure conferring risk.

5.
Online braz. j. nurs. (Online) ; Online braz. j. nurs. (Online);3(3): 27-36, dez. 2004.
Artículo en Portugués | LILACS, BDENF - Enfermería | ID: lil-418585

RESUMEN

A saúde bucal de idosos está abandonada pelos profissionais de saúde. Identifica-se a necessidade premente de ações interdisciplinares que possam mudar este quadro. O estudo teve como objetivo identificar o conteúdo sobre o cuidado com a saúde bucal em livros de enfermagem fundamental comumente utilizados em cursos de graduação em enfermagem. Com o método de revisão de literatura, o conteúdo foi identificado nas categorias: saúde bucal e processo de enfermagem; alterações do envelhecimento e patologias que afetam a saúde bucal; finalidade da higiene oral; material utilizado; o procedimento. A referência ao odontólogo é rara, inferindo que também a ele é relegada apenas uma parte da saúde bucal. Tecer as interfaces existentes entre a enfermagem e a odontologia associada à revisão de conceitos e implementação de ações é fundamental para a adequação do cuidado à saúde bucal do idoso.


Health providers have overlooked the dental health of the elderly. Interdisciplinary actions should be urgently promoted to change the current state of dental care delivery for the elderly. The purpose of this study was to analyze the content about oral health in textbooks commonly adopted in nursing graduate courses. Contents were classified into five categories: Oral health in nursing care; The aging changes and pathologies that affect oral health; Purposes of oral hygiene; Material used in dental care procedure; Dental care procedure. The analysis of these categories revealed that textbooks' priority focus is on the procedure. Discussion of patients' referral to dentists is rare, which shows that oral health is only partially assigned to these professionals. Geriatric nursing and dental care are faced with the challenge of working in association to review concepts and implement actions leading to more adequate dental care for the elderly.


Asunto(s)
Humanos , Higiene Bucal , Asistentes Dentales , Enfermería Geriátrica , Odontología Geriátrica , Salud Bucal
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA